药品上市许可持有人与流通企业的质量职责(1)
摘 要 通过分析上市持有人与流通企业在不同的商业模式、资质确认、药品溯源、药品信息披露、损害赔偿、行政处罚等方面不同的质量职责，提出了药品上市许可人制度已经改变了现有供应链分工模式，需进一步在法律法规中对这些质量职责进行明确，确保上市持有人制度对供给侧改革的积极效应。
关键词 药品上市持有人 流通企业 质量职责 供给侧改革
中图分类号：R951 文献标识码：C 文章编号：1006-1533(2017)15-0058-03
The quality responsibilities of marketing authorization holders and drug distribution enterprises
HUANG Weiwei*， TAN Yun， HUA Jia
(Shanghai Pharmaceutical Co.， Ltd.， Shanghai 200331， China)
ABSTRACT It is realized that the supply chain division pattern has been changed due to implementation of marketing authorization holder system based on analysis of the different quality responsibilities of marketing authorization holder and pharmaceutical distribution enterprise in different commercial models ......
您现在查看是摘要页，全文长 4305 字符。
关键词 药品上市持有人 流通企业 质量职责 供给侧改革
中图分类号：R951 文献标识码：C 文章编号：1006-1533(2017)15-0058-03
The quality responsibilities of marketing authorization holders and drug distribution enterprises
HUANG Weiwei*， TAN Yun， HUA Jia
(Shanghai Pharmaceutical Co.， Ltd.， Shanghai 200331， China)
ABSTRACT It is realized that the supply chain division pattern has been changed due to implementation of marketing authorization holder system based on analysis of the different quality responsibilities of marketing authorization holder and pharmaceutical distribution enterprise in different commercial models ......
您现在查看是摘要页，全文长 4305 字符。